IFF began funding two projects at the University of Texas following 2017’s WhatIFF Symposium. The projects are led by David Sandberg MD, Professor and Director of Pediatric Neurosurgery at the McGovern Medical School and The University of Texas MD Anderson Cancer Center, and Rachael Sirianni, PhD of the University of Texas Health Science Center at Houston. Dr. Sirianni was at Barrow Neurological Institute and met Dr. Sandberg as a result of the WhatIFF Symposium. The two doctors began working together after meeting at the event.
- Dr. Sandberg is researching innovative treatments focused on local drug delivery directly into the fourth ventricle of the brain. This research is a novel treatment approach for malignant tumors of the posterior fossa.
- Dr. Sirianni is researching innovative methods for drug treatment delivery in patients with medulloblastoma (MB,) the most common form of malignant brain tumors in children. Through this research, Dr. Sirianni hopes to identify safer and more effective drug delivery methods that will lead to better long-term outcomes for patients.